Cochrane Abstracts
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ataluren and Similar Compounds (specific Therapies for Premature Termination Codon Class I Mutations) for Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/Riluzole_for_amyotrophic_lateral_sclerosis__ALS__motor_neuron_disease__MND_:_Cochrane_systematic_review.
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/Riluzole_for_amyotrophic_lateral_sclerosis__ALS__motor_neuron_disease__MND_:_Cochrane_systematic_review. Accessed July 16, 2025.
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/Riluzole_for_amyotrophic_lateral_sclerosis__ALS__motor_neuron_disease__MND_:_Cochrane_systematic_review
Ataluren and Similar Compounds (specific Therapies for Premature Termination Codon Class I Mutations) for Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 July 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/Riluzole_for_amyotrophic_lateral_sclerosis__ALS__motor_neuron_disease__MND_:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis
ID - 434509
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/Riluzole_for_amyotrophic_lateral_sclerosis__ALS__motor_neuron_disease__MND_:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
